Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

phthalazinol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
1. Wilkins RH: Attempts at treatment of intracranial arterial spasm in animals and human beings. Surg Neurol 1: 148-159, 1973 2… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1982
1982
Hot water extracts of Mo-er (1 gm by 15 ml of water), an oriental food (Auricularia auricula), inhibit strongly both human and… Expand
Is this relevant?
1980
1980
Side effects of a drug sometimes lead to new uses. Phthalazinol is an inhibitor of cyclic adenosine monophosphate (cAMP… Expand
Is this relevant?
1980
1980
EG-626, 7-ethoxycarbonyl-6, 8-dimethyl-4-hydroxymethyl-1 (2H)-phthalazinone, was found to be a considerably potent cardiotonic… Expand
Is this relevant?
1980
1980
Effects of Phthalazinol (EG 626), a cyclic AMP phosphodiesterase inhibitor, a thromboxane A2 antagonist and an… Expand
Is this relevant?
1979
1979
Experiments in monkeys have demonstrated that the chronic vasospasm and arterial injury reaction produced by subarachnoid blood… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1979
1979
Abstract Effects of phthalazinol, EG 626, on the membrane and mechanical properties of the vascular smooth muscles, namely… Expand
Is this relevant?
1978
1978
Using an in vitro system designed to measure arterial constriction, we have demonstrated the importance of platelet function in… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1977
1977
The inhibitor constants of several inhibitors for cyclic AMP- and cyclic GMP-phosphodiesterase from various organs are compared… Expand
Is this relevant?
1976
1976
Three patients suffering from presenile dementia and two patients suffering from senile dementia were treated with phthalazinol… Expand
Is this relevant?